Table 1

Study subject serology results and indicators

Subjects

HCV PCR Copies per ml (Date of test)

HepBsAb

HepBsAg

HepBcAb

HIV Viral Load Copies per ml

ALT U/L

Liver Biopsy


1

10,800,000

(11/99)

Neg

Neg

Pos

633

(12/03)

32 (12/03)

Activity: Mild Stage 2 of 4

(08/00)

34,500,000 IU (12/03)

270,000

(01/03)


2

8,360,000

(09/99)

Neg

Neg

Pos

180,000

(10/03)

16

(02/04)

Not done due to bleeding diathesis

96,000

(02/04)

16

(10/03)


3

1,320,000

(10/03)

Pos

Neg

Pos

16,900

(02/04)

110

(10/03)

Grade 2/3 of 4 Stage 2/3 of 4 (11/03)

182

(02/04)


4

234,000

(12/02)

Neg

Neg

Neg

72,031

(12/02)

37

(12/03)

Grade 1 of 4 Stage 1 of 4

(11/03)

<50

(12/03)


5

<600

Neg

Neg

Pos

212,000

(10/03)

41

(10/03)

Not done

104

(04/04)


HCV = hepatitis C virus; HepB = hepatitis B; s = surface; c = core; Ab = antibody; Ag = antigen; HIV = human immunodeficiency virus; ALT = alanine aminotransferase enzyme

McMahon et al. Annals of Clinical Microbiology and Antimicrobials 2004 3:6   doi:10.1186/1476-0711-3-6

Open Data